nolpitantium besylate
Small moleculeexperimental
Clinical trial activity
1 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Apr 1, 2005 (NCT00232258)
Timeline
2000s
- Jan 1, 2005
Earliest Phase 2 Sponsor(trial)
Indications
Mechanism of action
- Tachykinin-3AGONIST
TAC3 agonist
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- nolpitantium besylate
- nolpitantium besylate
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00232258 | Phase 2 | Apr 1, 2005 | Katholieke Universiteit Leuven, Sanofi |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Katholieke Universiteit Leuven | Academic/Hospital | 1 | 0 | 1 | 2005 |
| Sanofi | For profit | 1 | 1 | 1 | 2005 |
2 organizations
Page 1 / 1